Compare BMR & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BMR | MDAI |
|---|---|---|
| Founded | 2009 | 2013 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.4M | 47.6M |
| IPO Year | 2023 | N/A |
| Metric | BMR | MDAI |
|---|---|---|
| Price | $1.94 | $1.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.25 |
| AVG Volume (30 Days) | 122.4K | ★ 286.6K |
| Earning Date | 08-13-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $3,131,000.00 | ★ $23,168,000.00 |
| Revenue This Year | $21.21 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5.96 | N/A |
| 52 Week Low | $1.54 | $1.04 |
| 52 Week High | $4.87 | $3.21 |
| Indicator | BMR | MDAI |
|---|---|---|
| Relative Strength Index (RSI) | 47.64 | 53.04 |
| Support Level | $1.54 | $1.41 |
| Resistance Level | $2.03 | $1.77 |
| Average True Range (ATR) | 0.13 | 0.08 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 75.00 | 59.47 |
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.